|
RCE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.463710E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.733600E-02 |
| Normal-vs-Stage2 |
2.63050000004483E-06 |
| Normal-vs-Stage3 |
2.675500E-03 |
| Normal-vs-Stage4 |
2.783300E-03 |
| Stage1-vs-Stage2 |
1.137360E-03 |
| Stage1-vs-Stage3 |
1.176970E-01 |
| Stage1-vs-Stage4 |
1.311410E-01 |
| Stage2-vs-Stage3 |
3.179800E-02 |
| Stage2-vs-Stage4 |
1.049820E-01 |
| Stage3-vs-Stage4 |
7.346200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.378040E-02 |
| Normal-vs-AfricanAmerican |
4.381800E-03 |
| Normal-vs-Asian |
9.427200E-01 |
| Caucasian-vs-AfricanAmerican |
1.169580E-01 |
| Caucasian-vs-Asian |
2.242000E-02 |
| AfricanAmerican-vs-Asian |
5.461300E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.518900E-03 |
| Normal-vs-Female |
4.716500E-03 |
| Male-vs-Female |
1.771380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.161160E-01 |
| Normal-vs-Age(41-60Yrs) |
3.201200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.78669999995051E-06 |
| Normal-vs-Age(81-100Yrs) |
4.253000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.953800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.200210E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.319800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.578140E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.507200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.445400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.365100E-04 |
| Classical-VS-Follicular |
2.1094237467878E-15 |
| Classical-VS-Other |
3.259200E-01 |
| Classical-VS-Normal |
2.839600E-01 |
| Tall-VS-Follicular |
2.43199999999666E-05 |
| Tall-VS-Other |
9.662000E-01 |
| Tall-VS-Normal |
5.005600E-04 |
| Follicular-VS-Other |
1.081820E-01 |
| Follicular-VS-Normal |
1.18180021324577E-10 |
| Other-VS-Normal |
1.468230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.222500E-04 |
| Normal-vs-N1 |
3.894000E-02 |
| N0-vs-N1 |
4.257000E-01 |
|
|
